Xeris Biopharma Holdings Inc. (XERS) NASDAQ

$2.21 0.17 (8.33%)

Market Cap: $310.40M

As of 03/28/24 04:00 PM EDT. Market closed.

(XERS)

Xeris Biopharma Holdings Inc. (XERS)
NASDAQ

$2.21
0.17 (8.33%)

Market Cap: $310.40M

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

xeris aspires to break through this restraint by developing ultra-low volume, ready-to-use biotherapeutics delivered through patient-friendly injectable devices. products built on our xeriject technologies could potentially ease the pain of injections for hundreds of millions of ... read more

xeris aspires to break through this restraint by developing ultra-low volume, ready-to-use biotherapeutics delivered through patient-friendly injectable devices. products built on our xeriject technologies could potentially ease the pain of injections for hundreds of millions of patients. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
Address
.
PRICE CHART FOR XERIS BIOPHARMA HOLDINGS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.12
Previous Close
$2.04
Days Range
$2.01 - $2.09
52 week range
$1.44 - $3.26
Volume
3,227,417
Avg. Volume (30 days)
2,429,279
Market Cap
$310.40M
Dividend Yield
-
P/E
(4.99)
Shares Outstanding
140,453,467
Open
$2.12
Previous Close
$2.04
Days Range
$2.01 - $2.09
52 week range
$1.44 - $3.26
Volume
3,227,417
Avg. Volume (30 days)
2,429,279
Market Cap
$310.40M
Dividend Yield
-
P/E
(4.99)
Shares Outstanding
140,453,467
FINANCIAL STATEMENTS FOR XERIS BIOPHARMA HOLDINGS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR XERIS BIOPHARMA HOLDINGS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
JOHNSON JOHNDirectorMar 18, 2024 Option Exercise$1.99215,600429,044751,412Mar 18, 2024, 05:32 PM
Schmid John P.DirectorMar 14, 2024 Buy$2.164,5009,72011,000Mar 14, 2024, 09:03 PM
SHERMAN JEFFREY WDirectorNov 27, 2023 Buy$1.875,40010,0985,400Nov 29, 2023, 04:09 PM
HALKUFF DAWNDirectorNov 20, 2023 Buy$1.845,4109,9545,410Nov 21, 2023, 04:20 PM
Pieper StevenSee RemarksNov 20, 2023 Buy$1.9528,00054,6001,176,912Nov 21, 2023, 04:16 PM
Schmid John P.DirectorNov 16, 2023 Buy$1.516,5009,8156,500Nov 17, 2023, 06:35 PM
Shannon John Patrick JrSee RemarksNov 17, 2023 Buy$1.6430,76950,4001,408,575Nov 17, 2023, 05:58 PM
PERSKY MARLADirectorNov 14, 2023 Buy$1.586,37010,0586,370Nov 15, 2023, 04:13 PM
Edick Paul RSee RemarksAug 09, 2023 Buy$2.3810,00023,7942,288,064Aug 09, 2023, 06:57 PM
Edick Paul RSee RemarksDec 13, 2022 Buy$1.4520,00029,0001,528,064Dec 14, 2022, 04:11 PM
BORMANN-KENNEDY BARBARA-JEAN ANNEDirectorJun 08, 2022 Option Exercise$2.1015,00031,50015,000Jun 09, 2022, 05:15 PM
Edick Paul RSee RemarksMay 12, 2022 Buy$1.40100,000140,3801,508,064May 13, 2022, 04:19 PM
PRESTRELSKI STEVENChief Scientific OfficerFeb 22, 2022 Option Exercise$0.6911,2287,747581,008Feb 24, 2022, 04:28 PM
PRESTRELSKI STEVENChief Scientific OfficerFeb 22, 2022 Sale$2.4211,22827,158569,780Feb 24, 2022, 04:28 PM
Edick Paul RSee RemarksNov 15, 2021 Buy$2.2820,00045,66433,430Nov 16, 2021, 04:25 PM
Shannon John Patrick JrSee RemarksNov 12, 2021 Buy$2.1060,000126,000363,829Nov 12, 2021, 05:12 PM
Shannon John Patrick JrSee RemarksNov 11, 2021 Buy$2.0940,00083,500303,829Nov 12, 2021, 05:12 PM
Edick Paul RSee RemarksNov 11, 2021 Buy$2.08200,000415,760808,064Nov 12, 2021, 05:09 PM
Pieper StevenSee RemarksNov 10, 2021 Buy$2.0025,00049,918183,108Nov 12, 2021, 05:06 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
JOHNSON JOHNDirector03/18/2024429,044
Schmid John P.Director03/14/20249,720
SHERMAN JEFFREY WDirector11/27/202310,098
HALKUFF DAWNDirector11/20/20239,954
Pieper StevenSee Remarks11/20/202354,600
Schmid John P.Director11/16/20239,815
Shannon John Patrick JrSee Remarks11/17/202350,400
PERSKY MARLADirector11/14/202310,058
Edick Paul RSee Remarks08/09/202323,794
Edick Paul RSee Remarks12/13/202229,000
BORMANN-KENNEDY BARBARA-JEAN ANNEDirector06/08/202231,500
Edick Paul RSee Remarks05/12/2022140,380
PRESTRELSKI STEVENChief Scientific Officer02/22/20227,747
PRESTRELSKI STEVENChief Scientific Officer02/22/202227,158
Edick Paul RSee Remarks11/15/202145,664
Shannon John Patrick JrSee Remarks11/12/2021126,000
Shannon John Patrick JrSee Remarks11/11/202183,500
Edick Paul RSee Remarks11/11/2021415,760
Pieper StevenSee Remarks11/10/202149,918
Load More Insider Transactions
FUNDS WITH A POSITION IN XERIS BIOPHARMA HOLDINGS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.10,011,3910.0006%6.8%Other
GEODE CAPITAL MANAGEMENT, LLC2,892,0770.00071%4.28%Other
RENAISSANCE TECHNOLOGIES LLC1,381,6400.00503%35.18%Other
D. E. SHAW & CO., INC.1,054,6100.00217%20.47%Other
TUDOR INVESTMENT CORP ET AL553,4110.01%-13.73%Event Driven, Other
ALPINE GLOBAL MANAGEMENT, LLC270,0000.2%-10%Event Driven
AQR CAPITAL MANAGEMENT LLC273,2220.00121%546.22%Other
FAIRFAX FINANCIAL HOLDINGS LTD/ CAN151,3950.02%No changeValue
CHANGE IN SHARES OUTSTANDING FOR XERIS BIOPHARMA HOLDINGS INC
STOCK BUYBACKS FOR XERIS BIOPHARMA HOLDINGS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.05%
1Q
12/31/2023
06/30/2023
0.58%
2Q
12/31/2023
03/31/2023
0.72%
3Q
12/31/2023
12/31/2022
1.57%
4Q
12/31/2023
09/30/2022
1.60%
5Q
12/31/2023
06/30/2022
1.92%
6Q
12/31/2023
03/31/2022
2.29%
7Q
12/31/2023
12/31/2021
74.79%
8Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.05%
1Q
06/30/2023
0.58%
2Q
03/31/2023
0.72%
3Q
12/31/2022
1.57%
4Q
09/30/2022
1.60%
5Q
06/30/2022
1.92%
6Q
03/31/2022
2.29%
7Q
12/31/2021
74.79%
8Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR XERIS BIOPHARMA HOLDINGS INC
LOADING...